The development of small molecule transmembrane anion transporters for the treatment of disease

Within this thesis novel receptors capable of binding and facilitating the transmembrane transport of biologically relevant anions are reported. Molecules based on the diindolylurea and tris(2-aminoethyl)amine scaffolds are described and their anion binding properties in both solution and in the sol...

Full description

Bibliographic Details
Main Author: Moore, Stephen J.
Other Authors: Gale, Philip
Published: University of Southampton 2012
Subjects:
Online Access:https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.568838
id ndltd-bl.uk-oai-ethos.bl.uk-568838
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-5688382018-09-05T03:19:51ZThe development of small molecule transmembrane anion transporters for the treatment of diseaseMoore, Stephen J.Gale, Philip2012Within this thesis novel receptors capable of binding and facilitating the transmembrane transport of biologically relevant anions are reported. Molecules based on the diindolylurea and tris(2-aminoethyl)amine scaffolds are described and their anion binding properties in both solution and in the solid state are reported. Inspired by the high affinities for oxo-anions measured for these molecules in polar solvent mixtures, the anion transport properties of structurally simple ureas and thioureas were studied. The high Cl-/NO3 - and Cl-/HCO3 - antiport activity observed with some of the thiourea compounds led to the development of more ‘drug-like’ transporters containing trifluoromethyl substituents. Fluorination of the transporter scaffold in this manner enhanced the lipophilicity and increased the acidity of the NH hydrogen-bond donor groups, leading to improvements in both anion affinity and transport activity. This work ultimately produced compounds capable of facilitating ion transport in vitro. A series of bisurea compounds based on the ortho-phenylenediamine scaffold are reported as potent ion transporters, capable of facilitating a range of ion transport processes. The introduction of electron withdrawing substituents was found to increase transporter activity. Of particular note is a para-nitrophenyl functionalised bisurea that facilitates chloride transport at a loading of 0.1 mmol % (with respect to lipid), the lowest loading of a synthetic mobile carrier to facilitate anion transport reported to date. Dual host systems for both M+/Cl- symport (M = Na, K or Rb) and Cl-/HCO3 - antiport are also described. By using different transporters to facilitate each uniport pathway in these coupled transport processes, it was possible to achieve enhanced ion transport rates. Remarkably, this is the first reported example of a dual host approach towards anion antiport.615.19QD ChemistryUniversity of Southamptonhttps://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.568838https://eprints.soton.ac.uk/344928/Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 615.19
QD Chemistry
spellingShingle 615.19
QD Chemistry
Moore, Stephen J.
The development of small molecule transmembrane anion transporters for the treatment of disease
description Within this thesis novel receptors capable of binding and facilitating the transmembrane transport of biologically relevant anions are reported. Molecules based on the diindolylurea and tris(2-aminoethyl)amine scaffolds are described and their anion binding properties in both solution and in the solid state are reported. Inspired by the high affinities for oxo-anions measured for these molecules in polar solvent mixtures, the anion transport properties of structurally simple ureas and thioureas were studied. The high Cl-/NO3 - and Cl-/HCO3 - antiport activity observed with some of the thiourea compounds led to the development of more ‘drug-like’ transporters containing trifluoromethyl substituents. Fluorination of the transporter scaffold in this manner enhanced the lipophilicity and increased the acidity of the NH hydrogen-bond donor groups, leading to improvements in both anion affinity and transport activity. This work ultimately produced compounds capable of facilitating ion transport in vitro. A series of bisurea compounds based on the ortho-phenylenediamine scaffold are reported as potent ion transporters, capable of facilitating a range of ion transport processes. The introduction of electron withdrawing substituents was found to increase transporter activity. Of particular note is a para-nitrophenyl functionalised bisurea that facilitates chloride transport at a loading of 0.1 mmol % (with respect to lipid), the lowest loading of a synthetic mobile carrier to facilitate anion transport reported to date. Dual host systems for both M+/Cl- symport (M = Na, K or Rb) and Cl-/HCO3 - antiport are also described. By using different transporters to facilitate each uniport pathway in these coupled transport processes, it was possible to achieve enhanced ion transport rates. Remarkably, this is the first reported example of a dual host approach towards anion antiport.
author2 Gale, Philip
author_facet Gale, Philip
Moore, Stephen J.
author Moore, Stephen J.
author_sort Moore, Stephen J.
title The development of small molecule transmembrane anion transporters for the treatment of disease
title_short The development of small molecule transmembrane anion transporters for the treatment of disease
title_full The development of small molecule transmembrane anion transporters for the treatment of disease
title_fullStr The development of small molecule transmembrane anion transporters for the treatment of disease
title_full_unstemmed The development of small molecule transmembrane anion transporters for the treatment of disease
title_sort development of small molecule transmembrane anion transporters for the treatment of disease
publisher University of Southampton
publishDate 2012
url https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.568838
work_keys_str_mv AT moorestephenj thedevelopmentofsmallmoleculetransmembraneaniontransportersforthetreatmentofdisease
AT moorestephenj developmentofsmallmoleculetransmembraneaniontransportersforthetreatmentofdisease
_version_ 1718728140753207296